Clinical Treatment Studies

Schizophrenia Trial

A multicenter, open-label study to assess hospitalization rates in adult subjects with schizophrenia treated prospectively for 6 months with Aripiprazole IM Depot compared with 6-month retrospective treatment with oral antipsychotics in a naturalistic community setting in the United States.

Participants must:

  • be between the ages of 18 and 65 years
  • have diagnosis of schizophrenia
  • have 1 inpatient psychiatric hospitalization within past 2 years
  • have no non-psychiatric hospitalization within past 4 weeks
  • currently be on oral antipsychotic treatment for past 7 months

Participants cannot:

  • have a history of head injury or other neurological disorder
  • have a current or past history of drug dependence
  • have significant extra pyramidal symptoms (tremors, akathisia) or tardive dyskinesia 
Alcohol Dependence Trial

This study uses psychotherapy in combination with an experimental mind-altering medication, administered in a clinical setting, to see if this approach promotes recovery from problems with alcohol. Medical and psychiatric evaluations as well as treatment interventions are conducted free of charge.

Participants must:

  • be between the ages of 25 and 65
  • be alcohol dependent
  • be concerned about their drinking
  • have at least 4 heavy drinking days in the past 30 days